IL13 and type 2 diabetes mellitus: People with T2DM and LTBI had a marginal suppression of immunity as demonstrated by the decreased total ILCs, ILC2 and ILC3 frequencies (Figure 2), as well as reduced IFN-γ and IL-13 cytokine production (Figure 3B).